FULL PAPER
H, Ar-H), 7.90 (d, J = 8.5 Hz, 4 H, pyridine-H), 8.10 (t, J = 7.0 Hz,
complex was recrystallized from a solution of acetonitrile/diethyl
2 H, pyridine-H) ppm. 13C{1H} NMR (125 MHz, [D6]DMSO, ether to yield complex 17 as a pale yellow solid in pure form, yield
1
298 K): δ = 13.8 (CH3), 21.7 (CH2CH3), 28.3 (CH2CH2CH3), 40.0 45 mg (80%), m.p. 190–191 °C. H NMR (500 MHz, [D6]DMSO,
(NCH2CH2), 48.7 (NCH2), 51.3 (CH2-pyridine), 120.7, 127.0, 133.2 298 K): δ = 3.17 (s, 6 H, 2 OCH3), 3.69 (t, J = 5.25 Hz, 4 H, 2
(benzimidazole Ar-C), 118.2, 125.7, 134.2 (pyridine Ar-C), 189.3
CH2-OCH3), 5.17 (t, J = 4.75 Hz, 4 H, 2 NCH2), 5.65 (s, 4 H, 2
CH2-pyridine), 7.70 (d, J = 6.0 Hz, 4 H, 2 imidazolium H4,H5),
7.83 (d, J = 8.0 Hz, 2 H, pyridine-H), 7.90 (t, J = 7.0 Hz, 1 H,
pyridine-H) ppm. 13C{1H} NMR (125 MHz, [D6]DMSO, 298 K):
(benzimidazolium C2-Ag) ppm. FTIR (KBr disk): ν = 2968, 3120
˜
ν(C–H, aliphatic and aromatic), 1601 ν(C=N, benzimidazole), 1563
ν(C=N, pyridine ring), 1055 ν(C–N, benzimidazole) cm–1
.
C62H74Ag2F12N10P2 (1464.99): calcd. C 50.8, H 5.1, N 9.6; found δ = 24.5 (OCH3), 28.8 (CH2-OCH3), 53.2 (NCH2), 55.5 (CH2-pyr-
C 50.3, H 5.2, N 9.4.
idine), 123.4, 129.0 (imidazolium C4Ј and C5Ј), 126.7, 144.0, 156.7
(pyridine Ar-C), 172.1 (imidazolium C2-Pd) ppm. FTIR (KBr
2,6-Bis(3-n-hexylbenzimidazol-1-ylmethyl)pyridinedisilver(I) Bis-
(hexafluorophosphate) (15): Synthesized in analogy to complex 12
by treating benzimidazolium hexafluorophosphate salt 10 (0.800 g,
1 mmol) with Ag2O (0.230 g, 1 mmol). The so-obtained crude com-
plex was recrystallized from a solution of methanol/diethyl ether to
yield complex 15 in pure form, yield 0.6 g (82%), m.p. 261–262 °C.
1H NMR (500 MHz, [D6]DMSO, 298 K): δ = 0.85 (t, J = 7.0 Hz,
12 H, 4 CH3), 1.20 (sext, 8 H, 4 CH2CH3), 1.30 (quint, 8 H, 4
CH2CH2CH3), 1.75 (quint, 8 H, 4 CH2CH2CH2CH3), 3.45 (quint,
8 H, 4 NCH2CH2), 4.45 (t, J = 7.5 Hz, 8 H, 4 NCH2), 5.90 (s, 8
H, 4 CH2-pyridine), 7.42 (t, J = 7.5 Hz, 4 H, Ar-H), 7.55 (d, J =
7.5 Hz, 4 H, Ar-H), 7.67 (t, J = 7.5 Hz, 4 H, Ar-H), 7.90 (d, J =
8.5 Hz, 4 H, pyridine-H), 8.05 (t, J = 7.0 Hz, 2 H, pyridine-H)
ppm. 13C{1H} NMR (125 MHz, [D6]DMSO, 298 K): δ = 13.8
( C H 3 ) , 2 1 . 7 ( C H 2 C H 3 ) , 2 8 . 3 ( C H 2 C H 2 C H 3 ) , 3 1 . 4
(CH2CH2CH2CH3), 40.0 (NCH2CH2), 48.7 (NCH2), 50.6 (CH2-
pyridine), 118.5, 120.7, 127.0 (benzimidazole Ar-C), 121.3, 133.2,
135.2 (pyridine Ar-C), 189.3 (benzimidazolium C2-Ag) ppm. FTIR
disc): ν = 2930, 2849 ν(C–H, aliphatic and aromatic), 1596 ν(C=N,
˜
imidazole), 1570 ν(C=N, pyridine ring), 1100 ν(C–N, imidazole),
1300 ν(C–O–C), 1270 ν(C–O) cm–1. C19H25ClF6N5O2PPd (642.25):
calcd. C 35.5, H 3.9, N 10.9; found C 35.9, H 4.0, N 11.2.
2,6-Bis(3Ј-allybenzimidazol-1-ylmethyl)pyridinepalladium(II) Hexa-
fluorophosphate (18): Synthesized in analogy to complex 16 by tre-
ating binuclear silver complex 13 (75 mg, 0.05 mmol) with
PdCl2(cod) (30 mg, 0.11 mmol). The so-obtained crude palladium
complex was recrystallized from a solution of acetonitrile/diethyl
ether to yield complex 18 as a yellow solid in pure form, yield
44 mg (60%), m.p. 198.5–199 °C. 1H NMR (500 MHz, [D6]DMSO,
2
298 K): δ = 5.25 (d, J = 6.0 Hz, 4 H, 2 NCH2), 5.36 (dd, JHH
=
1.5 Hz, 3JHH = 10.5 Hz, 2 H, CH=HHcis), 5.50 (dd, 2JHH = 1.5 Hz,
3JHH = 17.0 Hz, 2 H, CH=CHHtrans), 5.95 (d, J = 15.5 Hz, 2 H,
CH2-pyridyl), 6.28 (d, J = 15.5 Hz, 2 H, CH2-pyridyl), 6.12–6.18
(m, 2 H, 2 CH), 7.45 (t, J = 7.5 Hz, 4 H, 2 Ar-H), 7.52 (t, J =
7.5 Hz, 4 H, 2 Ar-H), 7.74 (t, J = 7.5 Hz, 2 H, Ar-H), 8.15 (d, J =
8.5 Hz, 2 H, pyridine-H), 8.25 (t, J = 7.5 Hz, 1 H, pyridine-H)
ppm. 13C{1H} NMR (125 MHz, [D6]DMSO, 298 K): δ = 50.7
(NCH2), 52.9 (CH2-pyridine), 111.8 (CH=CH2 ), 112.14
(CH=CH2), 118.2, 122.3, 128.6, 133.0 (benzimidazole Ar-C), 121.2,
133.4, 154.9 (pyridine Ar-C), 175.5 (benzimidazolium C2-Pd) ppm.
(KBr disk): ν = 2965, 3133 ν(C–H, aliphatic and aromatic), 1599
˜
ν(C=N, benzimidazole), 1583 ν(C=N, pyridine ring), 1050 ν(C–N,
benzimidazole) cm–1. C66H82Ag2F12N10P2 (1521.10): calcd. C 52.1,
H 5.4, N 9.2; found C 52.3, H 5.6, N 9.7.
Syntheses of Palladium(II)–NHC Complexes
FTIR (KBr disc): ν = 2860, 2924 ν(C–H, aliphatic and aromatic),
˜
2,6-Bis(3-allyimidazol-1-ylmethyl)pyridinepalladium(II) Hexafluoro-
phosphate (16): An acetonitrile (25 mL) solution of binuclear silver
complex 11 (58 mg, 0.05 mmol) and PdCl2(cod) (30 mg,
0.11 mmol) was stirred at 50 °C for 12 h in the dark. The reaction
was monitored by TLC, and upon completion of the reaction, the
mixture was filtered through a pad of Celite to remove precipitated
silver hexafluorophosphate, and the volatiles were removed under
vacuum. The so-obtained crude product was washed several times
with diethyl ether and recrystallized from an acetonitrile/hexane
mixture and dried under vacuum to yield CNC pincer-type palla-
dium complex 16 in pure form, yield 50 mg (79%), m.p. 181 °C. 1H
NMR (500 MHz, [D6]DMSO, 298 K): δ = 5.11 (d, J = 5.0 Hz, 4
1589 ν(C=N, benzimidazole), 1573 ν(C=N, pyridine ring), 1100
ν(C–N, benzimidazole) cm–1. C27H25ClF6N5PPd (706.34): calcd. C
45.9, H 3.6, N 9.9; found C 46.2, H 3.7, N 10.2.
2,6-Bis(3Ј-pentylbenzimidazol-1-ylmethyl)pyridinepalladium(II)
Hexafluorophosphate (19): Synthesized in analogy to complex 16
by treating binuclear silver complex 14 (73 mg, 0.06 mmol) with
PdCl2(cod) (33 mg, 0.12 mmol). The so-obtained crude palladium
complex was recrystallized from a solution of acetonitrile/hexane
to yield complex 19 as a pale yellow solid in pure form, yield 44 mg
1
(80%), m.p. 194 °C. H NMR (500 MHz, [D6]DMSO, 298 K): δ =
0.75 (t, J = 7.0 Hz, 6 H, 2 CH3), 1.25 (sext, 4 H, 2 CH2CH3), 1.35
( q u i n t , 4 H , 2 C H 2 C H 2 C H 3 ) , 1 . 9 5 ( q u i n t , 4 H , 2
CH2CH2CH2CH3), 4.95 (t, J = 6.5 Hz, 4 H, 2 NCH2), 5.85 (d, J
= 15.5 Hz, 2 H, CH2-pyridyl), 6.25 (d, J = 15.5 Hz, 2 H, CH2-
pyridyl), 7.48 (t, J = 7.0 Hz, 4 H, 2 Ar-H), 7.95 (d, J = 8.5 Hz, 4
H, 2 Ar-H), 8.10 (t, J = 7.5 Hz, 2 H, Ar-H), 8.15 (d, J = 8.5 Hz, 2
H, pyridine-H), 8.28 (t, J = 8.5 Hz, 1 H, pyridine-H) ppm. 13C{1H}
NMR (125 MHz, [D6]DMSO, 298 K): δ = 13.8 (CH3), 21.7
(CH2CH3), 28.3 (CH2CH2CH3), 40.0 (NCH2CH2), 48.7 (NCH2),
50.3 (NCH2-pyridine), 120.7, 127.0, 132.5 (benzimidazole Ar-C),
118.5, 123.6, 133.4, 138.5 (pyridine Ar-C), 175.0 (benzimidazolium
2
3
H, 2 NCH2), 5.16 (dd, JHH = 1.2 Hz, JHH = 11.0 Hz, 2 H,
2
3
CH=HHcis), 5.21 (dd, JHH = 1.2 Hz, JHH = 17.0 Hz, 2 H,
CH=CHHtrans), 5.67 (s, 4 H, 2 CH2-pyridine), 6.00–6.13 (m, 2 H,
2 CH), 7.85–7.90 (d, J = 6.0 Hz, 4 H, 2 imidazolium H4,H5), 7.92
(d, J = 8.0 Hz, 2 H, pyridine-H), 8.15 (t, J = 7.0 Hz, 1 H, pyridine-
H) ppm. 13C{1H} NMR (125 MHz, [D6]DMSO, 298 K): δ = 53.2
(NCH2), 55.5 (CH2-pyridine), 111.6 (CH=CH2), 122.9 (CH=CH2),
125.8, 129.0 (imidazolium C4Ј and C5Ј), 139.4, 143.0, 155.7 (pyr-
idine Ar-C), 171.6 (imidazolium C2-Pd) ppm. FTIR (KBr disc): ν
˜
= 3105, 2959 ν(C–H, aliphatic and aromatic), 1595 ν(C=N, benz-
imidazole), 1578 ν(C=N, pyridine ring), 1101 ν(C–N, imidazole)
cm–1. C19H21ClF6N5PPd (606.22): calcd. C 37.6, H 3.5, N 11.6;
found C 37.8, H 3.5, N 11.8.
C2-Pd) ppm. FTIR (KBr disc): ν = 2865, 2939 ν(C–H, aliphatic
˜
and aromatic), 1586 ν(C=N, benzimidazole), 1565 ν(C=N, pyridine
ring), 1105 ν(C–N, benzimidazole) cm–1. C31H37ClF6N5PPd
(766.48): calcd. C 48.6, H 4.9, N 9.1; found C 48.7, H 5.1, N 9.4.
2,6-Bis(3Ј-methoxyethylimidazol-1-ylmethyl)pyridinepalladium(II)
Hexafluorophosphate (17): Synthesized in analogy to complex 16 2,6-Bis(3Ј-hexylbenzimidazol-1-ylmethyl)pyridinepalladium(II)
by treating binuclear silver complex 12 (75 mg, 0.06 mmol) with
PdCl2(cod) (35 mg, 0.12 mmol). The so-obtained crude palladium
Hexafluorophosphate (20): Synthesized in analogy to complex 16
by treating binuclear silver complex 15 (74 mg, 0.06 mmol) with
Eur. J. Inorg. Chem. 2015, 3169–3181
3179
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim